CYG
TAK icon

Clean Yield Group’s Takeda Pharmaceutical TAK Stock Holding History

Clean Yield Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.41M Sell
238,365
-22,439
-9% -$394K 1.24% 28
2025
Q4 		$4.07M Sell
260,804
-5,234
-2% -$74.8K 1.13% 33
2025
Q3 		$3.89M Sell
266,038
-8,978
-3% -$133K 1.1% 35
2025
Q2 		$4.25M Sell
275,016
-11,540
-4% -$171K 1.27% 28
2025
Q1 		$4.26M Sell
286,556
-73,535
-20% -$1.03M 1.39% 22
2024
Q4 		$4.77M Sell
360,091
-46,137
-11% -$634K 1.52% 17
2024
Q3 		$5.78M Sell
406,228
-38,912
-9% -$552K 1.83% 14
2024
Q2 		$5.76M Sell
445,140
-36,312
-8% -$481K 2.15% 11
2024
Q1 		$6.69M Sell
481,452
-29,070
-6% -$423K 2.6% 8
2023
Q4 		$7.29M Sell
510,522
-22,635
-4% -$321K 3.07% 4
2023
Q3 		$8.17M Sell
533,157
-10,885
-2% -$169K 3.62% 3
2023
Q2 		$8.55M Buy
544,042
+1,700
+0.3% +$27.9K 3.52% 3
2023
Q1 		$8.94M Buy
542,342
+11,460
+2% +$183K 3.81% 3
2022
Q4 		$8.28M Buy
530,882
+23,754
+5% +$332K 3.56% 3
2022
Q3 		$6.58M Buy
507,128
+18,293
+4% +$254K 3.05% 4
2022
Q2 		$6.86M Buy
488,835
+237,615
+95% +$3.39M 2.84% 6
2022
Q1 		$3.6M Buy
+251,220
New +$3.69M 1.27% 28
2019
Q2 		– Sell
-372
Closed -$8K – 359
2019
Q1 		$8K Buy
+372
New +$7.49K ﹤0.01% 271

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clean Yield Group's TAK Position: Q1 2026 in Review

Clean Yield Group reduced its Takeda Pharmaceutical (TAK) stake by 8.6% in Q1 2026, selling an estimated $394K and leaving 238,365 shares worth $4.41M. The position accounts for 1.24% of the portfolio, ranked #28.

Clean Yield Group first reported a position in TAK in Q1 2019 and has held it in 18 quarters since. The position peaked at $8.94M in Q1 2023. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Clean Yield Group held 238,365 shares of Takeda Pharmaceutical worth $4.41M as of Q1 2026.
  • Clean Yield Group sold 22,439 Takeda Pharmaceutical shares in Q1 2026, an estimated $394K.
  • Takeda Pharmaceutical made up 1.24% of Clean Yield Group's portfolio in Q1 2026, its #28 holding.
  • Clean Yield Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
  • Clean Yield Group's Takeda Pharmaceutical position peaked at $8.94M in Q1 2023.
  • 359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.